Randomized clinical trial of surgical vs. percutaneous vs. hybrid revasculatization in multivessel coronary artery disease: 3 years follow-up (the HREVS Trial)

1 September 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Cardiovascular Surgery Potpourri Coronary Arteries ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by